X0407 4 2023-06-30 0 0001706431 Vir Biotechnology, Inc. VIR 0001782338 SVF Endurance (Cayman) Ltd C/O WALKERS CORP LTD., 190 ELGIN AVENUE GEORGE TOWN E9 KY1-9008 CAYMAN ISLANDS 0 0 1 0 0001731509 SB INVESTMENT ADVISERS (UK) LTD 69 GROSVENOR STREET LONDON X0 W1K 3JP UNITED KINGDOM 0 0 1 0 0001755143 SOFTBANK VISION FUND (AIV M1) L.P. 251 LITTLE FALLS DRIVE WILMINGTON DE 19808 0 0 1 0 0 Common Stock 2023-06-30 4 S 0 700 25.11 D 16684041 I See footnote The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. ("SVF"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as alternative investment fund manager ("AIFM") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments. SVF Endurance (Cayman) Limited, By: /s/ Rhonda Gornitsky, Director 2023-07-05 SoftBank Vision Fund (AIV M1) L.P., By: SB Investment Advisers (UK) Limited, its manager, By: /s/ Amanda Sanchez-Barry, General Counsel 2023-07-05 SB Investment Advisers (UK) Limited, By: /s/ Amanda Sanchez-Barry, General Counsel 2023-07-05